4.5 Article

Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure

期刊

JACC-HEART FAILURE
卷 9, 期 11, 页码 824-835

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2021.05.013

关键词

accelerometer; exercise testing; hemodynamics; HFrEF; patient-centric outcome

资金

  1. Danish Heart Foundation
  2. Steno Diabetes Center Odense, Denmark
  3. A.P. MOller Foundation for the Advancement of Medical Science [17-L-0339]
  4. A.P. MOller Foundation
  5. Research Council at Herlev and Gentofte University Hospital,Denmark
  6. Research and Innovation Foundation of the Department of Cardiology
  7. Herlev and Gentofte Uni-versity Hospital, Denmark
  8. A.P. MOller Foundation for the Advancement of Medical Science, Denmark
  9. Boehringer Ingelheim
  10. Novartis
  11. Pfizer
  12. Orion Pharma Abbott
  13. Carmat
  14. National Institutes of Health [R01 HL1285 26]
  15. Capital Region of Denmark
  16. AstraZeneca
  17. Novo Nordisk
  18. Abiomed
  19. Orion Pharma

向作者/读者索取更多资源

Lower daily activity recorded by accelerometer is associated with decreased cardiac index at rest and during exercise in patients with heart failure with reduced ejection fraction.
OBJECTIVES This study examined the link between accelerometer recordings and cardiac pathophysiology measured with right heart cauterization at rest and with exercise in patients with HFrEF. BACKGROUND Patient-worn accelerometers are increasingly being used in patients with heart failure with reduced ejection fraction (HFrEF) to assess activity and serve as surrogate endpoints in heart failure trials. METHODS Physical average daily activity (PADA) and total average daily activity according to accelerometer units were assessed in 63 patients (mean age 58 +/- 10 years; mean ejection fraction 26% +/- 4%). Patients underwent hemodynamic exercise testing and accelerometry. Patients were divided according to PADA in PADA(Low) and PADA(High) activity level groups based on median counts per minute of physical activity. RESULTS Patients in the PADA(Low) group were older and more frequently treated with diuretics. At rest, the PADA(Low) group was characterized by a lower cardiac index (2.2 +/- 0.4 L/min/m(2) vs 2.4 +/- 0.4 L/min/m(2); P = 0.01) and stroke volume (70 +/- 19 mL vs 81 +/- 17 mL; P = 0.02) but not pulmonary capillary wedge pressure (12 +/- 5 mm Hg vs 11 +/- 5 mm Hg; P = 0.3). The PADA(Low) group reached a lower cardiac index (4.8 +/- 1.7 L/min/m(2) vs 6.6 +/- 1.7 L/min/m(2); P < 0.001) but not in pulmonary capillary wedge pressure (31 +/- 12 mm Hg vs 27 +/- 8 mm Hg; P = 0.2) at peak exercise. The attenuated increase was associated with an attenuated increase in stroke volume (94 +/- 32 mL vs 121 +/- 29 mL; P < 0.001) rather than a reduced increase in heart rate (42 +/- 23 beats/min vs 52 +/- 21 beats/min; P = 0.07). PADA and total average daily accelerometer units were associated with patient-reported functional impairment according to the Kansas City Cardiomyopathy Questionnaire but not with New York Heart Association functional class. CONCLUSIONS Among stable ambulatory patients with HFrEF, lower daily activity is associated with poorer cardiac index reserve and reduced cardiac index during exercise. (C) 2021 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据